Answers are grounded in this paper and cite their sources.
Preclinical study reveals mutant ACVR1 elevates hypoxia signaling and vascularity in pediatric diffuse midline glioma, highlighting hypoxia-inducible factors in tumor growth.
Background Pediatric diffuse midline gliomas (pDMG) are lethal tumors, with approximately 80% harboring a lysine-to-methionine mutation in histone H3, leading to reduced H3K27 trimethylation and subsequently a unique epigenetic landscape. Approximately 25% also carry activating mutations in ACVR1, encoding the BMP receptor ALK2. While ACVR1 mutations are known to activate BMP signaling in pDMG, the extent to which this contributes to gliomagenesis, and the downstream pathways involved, remain poorly understood. Notably, ACVR1 mutations are also found in the rare disorder Fibrodysplasia ossificans progressiva (FOP), and evidence from FOP models has suggested several links between hypoxia signaling, BMP signaling, indicating that hypoxia signaling may contribute to ACVR1-driven gliomagenesis in pDMG. Methods We analyzed clinical gene expression datasets to compare hypoxia signature scores between ACVR1 mutant and wildtype pediatric gliomas. Activity of the hypoxia pathway was functionally assessed in a genetically engineered mouse model of pDMG, in cultured pDMG and adult glioma cells, as well as in NSC-derived experimental pDMG cultures. Results Hypoxia signature scores were elevated in pediatric gliomas with mutant ACVR1 as compared to ACVR1 wildtype. In vitro, activation of ACVR1 in pDMG cells showed significantly increased hypoxia signaling and enhanced HIF-2α expression under low oxygen conditions, a response absent in adult glioma cells. ACVR1-mutated murine pDMGs were more vascularized than wildtype controls, and displayed enhanced expression of HIF-2α. Nevertheless, genetic and pharmacological targeting of HIF-2α was insufficient to affect ACVR1-mediated hypoxia signaling. Conclusions Our findings demonstrate that ACVR1 mutations enhance hypoxia signaling in pDMG, and highlight HIF-1α and HIF-2α as potential mediators of the ACVR1-driven pDMG gene expression profile.
No takes yet. Share an insight, caveat, or question.
Johansson et al. (2026) studied this question.